Filing Details
- Accession Number:
- 0000899243-22-028246
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-10 16:06:06
- Reporting Period:
- 2022-08-08
- Accepted Time:
- 2022-08-10 16:06:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-08 | 1,304 | $187.53 | 37,381 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-08 | 222 | $290.32 | 37,159 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-08 | 424 | $291.53 | 36,735 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-08 | 210 | $293.02 | 36,525 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-08 | 302 | $293.99 | 36,223 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-08 | 146 | $295.14 | 36,077 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-08 | 1,304 | $0.00 | 1,304 | $187.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,607 | 2029-02-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
- Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $290.32 (range $290.05 to $290.64).
- Open market sales reported on this line occurred at a weighted average price of $291.53 (range $291.06 to $291.91).
- Open market sales reported on this line occurred at a weighted average price of $293.02 (range $292.41 to $293.36).
- Open market sales reported on this line occurred at a weighted average price of $293.99 (range $293.58 to $294.26).
- Open market sales reported on this line occurred at a weighted average price of $295.14 (range $294.74 to $295.53).
- The option vests in 16 quarterly installments from 2/6/2019.
Billionaire Hedge Funds
